Literature DB >> 125290

Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

J J Twomey, A H Laughter, S Farrow, C C Douglass.   

Abstract

Irradiated leukocytes or mononuclear leukocytes, from 16 out of 30 patients with Hodgkin's disease and from one patient with the Sézary syndrome, stimulated in culture subnormal (3H)thymidine incorporation by allogeneic lymphocytes from normal individuals. This abnormality was not demonstrated in any of 30 other patients with non-Hodgkin's lymphomas. Subnormal mixed leukocyte culture reaction activation was caused by suppression of the mixed leukocyte reaction by patients' cells. Inhibition of the reaction by patient mononuclear leukocytes was corrected when adherent cells were removed or when protein synthesis was inhibited with cycloheximide. The inhibitory cells were probably lymphocytes since selective removal of phagocytic cells did not remove the inhibition by other patient mononuclear leukocytes. The presence in culture of as few as 2,500 granulocytes per mm3 also reduced responses when target cells were from patients with Hodgkin's disease. Patient cells no longer suppressed the mixed leukocyte reaction after patients entered clinical remission which suggests that suppression is a reversible, disease-related abnormality. Thus, the immune deficiency with advance Hodgkin's disease caused by ly lymphocyte depletion may be compounded by a relative excess of suppressor lymphocytes. The overall immunodeficiency may be further compounded by suppression of immune response by granulocytes at even physiologic concentrations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125290      PMCID: PMC436607          DOI: 10.1172/JCI108113

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

2.  Biological and pathogenic properites of a mouse leukemia virus.

Authors:  L GROSS
Journal:  Acta Haematol       Date:  1960-05       Impact factor: 2.195

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Antibody activity of human myeloma globulins.

Authors:  M Seligmann; J C Brouet
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

5.  Response of lymphocytes in chronic lymphocytic leukaemia to plant mitogens.

Authors:  J L Smith; D C Cowling; C R Barker
Journal:  Lancet       Date:  1972-01-29       Impact factor: 79.321

6.  Production by stimulated macrophages of factors depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Nature       Date:  1973-11-30       Impact factor: 49.962

7.  T or B cell origin of some non-Hodgkin's lymphomas.

Authors:  C R Peter; M R MacKenzie; F J Glassy
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

8.  Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction.

Authors:  N L Gerber; J A Hardin; T M Chused; A D Steinberg
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

9.  The HL-A system. I. Genetics and molecular biology.

Authors:  R Ceppellini; J J van Rood
Journal:  Semin Hematol       Date:  1974-07       Impact factor: 3.851

10.  Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation.

Authors:  E Rabellino; S Colon; H M Grey; E R Unanue
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

View more
  56 in total

Review 1.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

2.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

3.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

4.  The importance of protease histochemistry in pathology.

Authors:  Z Lojda
Journal:  Histochem J       Date:  1985-10

5.  Effects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cells.

Authors:  T J Sims; R C Page
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).

Authors:  C Morimoto
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

7.  Nephrotic syndrome of childhood and disorder of T cell function.

Authors:  H Schulte-Wissermann; E M Lemmel; M Reitz; J Beck; E Straub
Journal:  Eur J Pediatr       Date:  1977-01-26       Impact factor: 3.183

8.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

9.  Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.

Authors:  G W Wood; R A Morantz
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

10.  Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.

Authors:  S Gupta
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.